{{expand|time=2015-10-13T22:44:09+00:00}}
{{refimprove|time=2015-10-13T22:44:09+00:00}}

{{medical}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 457818137
| IUPAC_name =  (3''R'',5a''S'',6''R'',8a''S'',9''R'',10''S'',12''R'',12a''R'')-10-methoxy-3,6,9-trimethyldecahydro-12''H''-3,12-epoxy[1,2]dioxepino[4,3-''i'']-2-benzopyran
| image = artemether.svg
| image2 = Artemether 3D balls.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|artemether}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = POM
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = 口服

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 71963-77-4
| ATC_prefix = P01
| ATC_suffix = BE02
| ATC_supplemental =  
| PubChem = 68911
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB06697
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 62138
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = C7D6T3H22J
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02483
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 195280
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1237051

<!--Chemical data-->
| chemical_formula =  
| C=16 | H=26 | O=5 
| molecular_weight = 298.374 g/mol
| smiles = C[C@@H]1CC[C@@H]3C42OO[C@](C)(CC[C@@H]12)O[C@H]4O[C@H](OC)[C@@H]3C
| InChI = 1/C16H26O5/c1-9-5-6-12-10(2)13(17-4)18-14-16(12)11(9)7-8-15(3,19-14)20-21-16/h9-14H,5-8H2,1-4H3/t9-,10-,11+,12+,13+,14-,15-,16?/m1/s1
| InChIKey = SXYIRMFQILZOAM-LJXHFVHTBB
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H26O5/c1-9-5-6-12-10(2)13(17-4)18-14-16(12)11(9)7-8-15(3,19-14)20-21-16/h9-14H,5-8H2,1-4H3/t9-,10-,11+,12+,13+,14-,15-,16-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SXYIRMFQILZOAM-HVNFFKDJSA-N
}}

'''蒿甲醚'''（{{lang-en|'''artemether'''}}）是一种用来治疗多药[[耐药|耐药]][[恶性疟原虫|恶性疟原虫]][[疟疾|疟疾]]的[[抗疟药|抗疟药]]。[[诺华|诺华]]首次以其与Riamet和Coartem为商品名出售其与[[本芴醇|本芴醇]]共同组成的[[复方|复方]]药物。

化学上，蒿甲醚是[[青蒿素|青蒿素]]的[[半合成|半合成]][[衍生物|衍生物]]。

<!-- Society and culture -->
青蒿琥酯被列入[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]，是最重要的基本健康药物之一。<ref>{{cite web|title=WHO Model List of EssentialMedicines|url=http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|work=World Health Organization|accessdate=22 April 2014|date=October 2013}}</ref>

==作用机制==
青蒿素无论在体内和体外的实验中均对[[疟疾|疟疾]]有很好的杀灭效果。<ref name="dxy_art1">{{cite web | url=http://infect.dxy.cn/article/142516 | title=2015 诺贝尔生理学或医学奖：青蒿素与疟疾 | accessdate=6 October 2015}}</ref>

青蒿素的作用机制尚不十分清楚，主要是干扰疟原虫的[[表膜-线粒体|表膜-线粒体]]功能。青蒿素通过影响[[疟原虫|疟原虫]][[红内期|红内期]]的超微结构，使其膜系结构发生变化。由于对[[食物泡膜|食物泡膜]]的作用，阻断了疟原虫的营养摄取，当疟原虫损失大量胞浆和营养物质，而又得不到补充，因而很快死亡。其作用方式是通过其内过氧化物(双氧)桥，经血红蛋白分解后产生的游离[[铁|铁]]所介导，产生不稳定的有机自由基及/或其他亲电子的中介物，然后与疟原虫的蛋白质形成[[共价加合物|共价加合物]]，而使疟原虫死亡。<ref name="medref">{{cite web | url=http://drugref.medlive.com.cn/drugref/drug_info.do?id=3188 | title=青蒿素栓_化生药说明书_临床用药参考 | accessdate=6 October 2015}}</ref> 2015年，Wang等人利用化学蛋白质组学的技术手段合成了基于青蒿素结构的化学探针，准确的鉴定出了青蒿素在疟原虫中的100多个蛋白靶点，并且确定了青蒿素的激活依赖于疟原虫中生成的大量血红素。<ref>{{cite journal | vauthors = Wang J, Zhang CJ, Chia WN, Loh CC, Li Z, Lee YM, He Y, Yuan LX, Lim TK, Liu M, Liew CX, Lee YQ, Zhang J, Lu N, Lim CT, Hua ZC, Liu B, Shen HM, Tan KS, Lin Q | title = Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum | journal = Nature Communications | volume = 6 | pages = 10111 | pmid = 26694030 | doi = 10.1038/ncomms10111 | pmc=4703832 | year=2015}}</ref>
== 参考文献 ==
{{Reflist|30em}}

{{-}}
{{Chromalveolate antiparasitics}}

[[Category:抗原虫药|Category:抗原虫药]]